Business & Finance
Finding the profit prescription
Pharmaceutical companies are striking mega deals, diversifying and cutting costs but Wall Street skepticism persists in many corners of the healthcare industry. Full Coverage
Industries News
Finance News
Reuters Business Blogs
- DealZone
- MediaFile
- Shoptalk
| Symbol | Last | Net Change |
|---|---|---|
| BRENT CRUDE | $75.74 | $-2.21 |
| MINI SILVER | $0.00 | $0.00 |
| 100 OZ GOLD | $1,102.80 | $-11.80 |
Today's Company Results
Hassan sees Merck retaining Remicade
NEW YORK (Reuters) - Fred Hassan, former head of Schering-Plough Corp, said Merck & Co is likely to prevail over Johnson & Johnson in its battle to retain overseas rights to the blockbuster arthritis drug Remicade. Full Article
